@vrs37 ...
Are you aware physicians requested patients remain on DMX200 following completion of phase 2 trial? Numerous patients remained on the treatment post clinical trial. What does that say about futility?
Advanz have done due diligence on all data from Phase 2 (and earlier) trials. They have seen behind the curtain and stumped up a $10m cash prepayment. What does that say about futility?
They say there is no such thing as a stupid question, but the answers are all out there if you could just be bothered to look, instead if trying to spread fear and panic.
If you've any doubt where my confidence comes from, I'll make it clear: I place way more value on Advanz Pharma's research and opinion than yours.
@vrs37 ...Are you aware physicians requested patients remain on...
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.055(9.91%) |
Mkt cap ! $335.3M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 61.5¢ | 56.5¢ | $1.938M | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3652 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 27035 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |